[ad_1]
Do you want to know how much pharmaceutical companies can earn from the sale of COVID vaccines?
Astrazeneca received orders for 3.2 billion vaccines. The cost of a vaccine is $ 4. Revenue: $ 12.8 billion! This is half of the revenue the company received in 2019: $ 24.3 billion.
Pfizer has received orders for 1.1 billion vaccines. Cost – $ 19.5 Revenue: $ 21.5 billion! This is also half of the revenue the company received in 2019: $ 51.75 billion.
And the most interesting.
Modern. Orders for 800 million vaccines. Price from 10 to 50 dollars. For example, the United States bought 100 million vaccines at $ 15 each. This is $ 1.5 billion! Potential revenue will be in the range of $ 8 billion to $ 40 billion.
Do you know what income the company received in 2019? $ 60 million (not 1 billion) And it turns out that thanks to the epidemic, a small and hitherto unknown company will receive revenue like the world’s leading pharmaceutical companies.
How did you get into this club? Everything is simple. In May 2020, Trump announced the Warp Speed program. Under it, the United States government funded the efforts of pharmaceutical companies to develop a vaccine.
And Moderna received $ 800 million in grants from the state. And then an order for $ 1.5 billion. By the way, Astrazeneka and Pfizer also received grants from the United States.
With a wave of the hand, the United States government created the future pharmaceutical giant.
By the way, it’s not surprising that the company’s capitalization is now $ 56 billion.
We live in incredible times.
